BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7464772)

  • 1. Evaluation of a long-acting injectable oxytetracycline.
    Cornwell RL
    Mod Vet Pract; 1980 Nov; 61(11):945-7. PubMed ID: 7464772
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of an experimental long-acting oxytetracycline (Terramycin/LA) in the treatment of acute anaplasmosis.
    Kuttler KL; Young MF; Simpson JE
    Vet Med Small Anim Clin; 1978 Feb; 73(2):187-92. PubMed ID: 245908
    [No Abstract]   [Full Text] [Related]  

  • 3. Bovine anaplasmosis: elimination of the carrier state with injectable long-acting oxytetracycline.
    Swift BL; Thomas GM
    J Am Vet Med Assoc; 1983 Jul; 183(1):63-5. PubMed ID: 6874524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of a new oxytetracycline formulation against clinical anaplasmosis.
    Magonigle RA; Simpson JE; Frank FW
    Am J Vet Res; 1978 Sep; 39(9):1407-10. PubMed ID: 697150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a new long-acting oxytetracycline formulation against anaplasmosis in colombian cattle.
    Todorovic RA; Gonzalez EF; Garcia O
    Tropenmed Parasitol; 1979 Jun; 30(2):236-8. PubMed ID: 483386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elimination of the carrier state of bovine anaplasmosis with a long-acting oxytetracycline.
    Roby TO; Simpson JE; Amerault TE
    Am J Vet Res; 1978 Jul; 39(7):1115-6. PubMed ID: 677530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of a short and a long acting oxytetracycline for the treatment of Anaplasma marginale in splenectomized calves.
    Stewart CG; Immelman A; Grimbeek P; Grib D
    J S Afr Vet Assoc; 1979 Jun; 50(2):83-5. PubMed ID: 551196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elimination of naturally acquired chronic Anaplasma marginale infections with a long-acting oxytetracycline injectable.
    Magonigle RA; Newby TJ
    Am J Vet Res; 1982 Dec; 43(12):2170-2. PubMed ID: 7165161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bovine anaplasmosis: clinical, hematologic, and serologic manifestations in cows given a long-acting oxytetracycline formulation in the prepatent period.
    Lincoln SD; Eckblad WP; Magonigle RA
    Am J Vet Res; 1982 Aug; 43(8):1360-2. PubMed ID: 7103219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative efficacy of two oxytetracycline formulations and doxycycline in the treatment of acute anaplasmosis in splenectomized calves.
    Kuttler KL; Simpson JE
    Am J Vet Res; 1978 Feb; 39(2):347-9. PubMed ID: 629473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined treatment with a dithiosemicarbazone and oxytetracycline to eliminate Anaplasma marginale infections in splenectomized calves.
    Kuttler KL
    Res Vet Sci; 1972 Nov; 13(6):536-9. PubMed ID: 4648995
    [No Abstract]   [Full Text] [Related]  

  • 12. The elimination of Anaplasma marginale from carrier cattle by treatment with long acting oxytetracycline.
    Rogers RJ; Dunster PJ
    Aust Vet J; 1984 Sep; 61(9):306. PubMed ID: 6517790
    [No Abstract]   [Full Text] [Related]  

  • 13. Cure of Dermatophilus congolensis infection in cattle by long-acting oxytetracycline.
    Ilemobade AA; Gyang EO; Bida SA; Addo PB
    Res Vet Sci; 1979 Nov; 27(3):302-5. PubMed ID: 542717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of five daily intravenous treatments with oxytetracycline hydrochloride on the carrier status of bovine anaplasmosis.
    Magonigle RA; Renshaw HW; Vaughn HW; Stauber EH; Frank FW
    J Am Vet Med Assoc; 1975 Dec; 167(12):1080-3. PubMed ID: 1194114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of oxytetracycline and a dithiosemicarbazone in the treatment of bovine anaplasmosis.
    Kuttler KL
    Am J Vet Res; 1971 Sep; 32(9):1349-52. PubMed ID: 5094519
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of a second Anaplasma exposure on the success of treatment to eliminate Anaplasma carrier infections in cattle.
    Kuttler KL
    Am J Vet Res; 1983 May; 44(5):882-3. PubMed ID: 6869997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy to eliminate Anaplasma marginale under field and laboratory conditions.
    Kuttler KL; Johnson LW; Simpson JE
    Proc Annu Meet U S Anim Health Assoc; 1980; 84():73-82. PubMed ID: 6947300
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunity to bovine anaplasmosis after elimination of the carrier status with oxytetracycline hydrochloride.
    Renshaw HW; Magonigle RA; Eckblad WP; Frank FW
    Proc Annu Meet U S Anim Health Assoc; 1976; (80):79-88. PubMed ID: 1078098
    [No Abstract]   [Full Text] [Related]  

  • 19. Anaplasmosis: prevalence, treatment, and cattle to elk transmission studies.
    Renshaw HW; Magonigle RA; Stauber EH; Vaughn HW; Frank FW
    Proc Annu Meet U S Anim Health Assoc; 1975; (79):70-84. PubMed ID: 1078068
    [No Abstract]   [Full Text] [Related]  

  • 20. Oestradiol combined with oxytetracycline as therapy for severe bovine anaplasmosis.
    Zaugg JL
    Vet Rec; 1998 Jan; 142(2):44. PubMed ID: 9481829
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.